杨宁介入医学网

The term non-cirrhotic portal hypertension (NCPH) refers to a heterogeneous group of liver disorders that primarily affect the liver vascular system and that are classified anatomically on the basis of site of resistance to blood flow, as...

Porto sinusoidal vascular liver disease (PSVD) is a vascular liver disease characterized by portal hypertension in the absence of cirrhosis and other causes of liver disease[1]. 门窦性血管性肝病(PSVD)是一种以血管性肝病为特征的门静脉高压，...

发病机制 到目前为止，INCPH 的具体病理生理机制尚不 明确。分二元理论和统一理论 二元理论： 认为，肝内血管闭塞所致 门静脉血流阻力增加和脾大继发门静脉血流增加是 导致 INCPH 患者门静脉高压的两个主要因素。肝 内血管闭塞的具体原因尚不清楚 统一理论：...

INCPH 在世界各地都有报道，它在西方较为罕 见，而在发展中国家，其发病率更高。性别比例在不同国家有所不同，在西方国家和印度多见于男 性，而在日本则多发于女性。发病年龄不定，在印度，其发病年龄约 25 ～ 35 岁，在日本，其发病年龄约 50 岁，而 在 西...

Optimal stent diameter The 8-mm vs 10-mm debate: The availability of covered stents for TIPS has significantly reduced the incidence of stent dysfunction with attendant improvement in patient outcomes[206]. 最佳支架直径 8mm和10mm的争论：覆...

Complications of portal hypertension, including ascites, gastrointestinal bleeding, hepatic hydrothorax, and hepatic encephalopathy, are associated with significant morbidity and mortality. 门脉高压的并发症，包括腹水、胃肠出血、肝性胸水和...

In patients who have gastro-oesophageal variceal bleeding refractory to endoscopic and drug therapy as defined by Baveno 6 critera,32 transjugular intrahepatic portosystemic stent-shunt (TIPSS) is recommended (strong recommendation, modera...

The role of early or pre-emptive TIPSS in acute variceal bleeding in view of the conflicting evidence and uncertainly about patient selection. 鉴于相互矛盾的证据和不确定的患者选择，早期或先发制人的TIPSS在急性静脉曲张出血中的作用。 Large mu...

Abstract These guidelines on transjugular intrahepatic portosystemic stent-shunt (TIPSS) in the management of portal hypertension have been commissioned by the Clinical Services and Standards Committee (CSSC) of the British Society of Gast...

关于标记门静脉 在长期的临床应用中，TIPS介入医生始终在尝试，使这一基本靠蒙的盲目的的操作，变得更为有目标性，从而缩短操作时间并增加其安全性。用于穿刺门静脉标记方法包括术前经皮门脉内植入标志物，作为经颈静脉穿刺门静脉的方向标志；实时超声引导，...